Psychiatry and Neurology, Neurology · Brooklyn, NY
NPI
1265445639
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
56 Brighton 11th St Ste 2a
Brooklyn, NY, 11235
Phone (917) 655-7374
Groups this clinician bills Medicare through
Medicare paid, 2024
$602K
25,211 services
Medicare patients, 2024
858
Average age 76
Drug cost, 2024
$3.7M
18,751 prescriptions
Company payments, 2025
$12K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dmitriy Grinshpun was code J0585 (injection, onabotulinumtoxina, 1 unit), 20,100 times for 37 patients. In total Dmitriy Grinshpun billed 25,211 services in 30 codes, and Medicare paid $602K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 20,100 | 37 | $4.98 | $100K |
| 99213 Office E&M - Established | Office | 1,795 | 686 | $73.83 | $133K |
| 95886 Electrical Nerve Conductivity | Office | 1,218 | 439 | $79.50 | $97K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 383 | 80 | $0.77 | $294 |
| 95911 Electrical Nerve Conductivity | Office | 298 | 279 | $172.70 | $51K |
| 99204 Office E&M - New | Office | 273 | 273 | $138.05 | $38K |
| 95819 Neurologic | Office | 248 | 246 | $386.25 | $96K |
| 95913 Electrical Nerve Conductivity | Office | 154 | 154 | $234.02 | $36K |
| 20610 Joint Injection | Office | 93 | 68 | $69.32 | $6,447 |
| 64615 Musculoskeletal | Office | 85 | 32 | $136.57 | $12K |
| 93886 Ultrasound - Nonspecific | Office | 49 | 48 | $228.96 | $11K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 47 | 46 | $128.23 | $6,027 |
| 99203 Office E&M - New | Office | 32 | 32 | $92.90 | $2,973 |
| 20526 Musculoskeletal | Office | 15 | 13 | $86.34 | $1,295 |
By year: 2022 $500K for 19,254 services; 2023 $581K for 21,805 services; 2024 $602K for 25,211 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dmitriy Grinshpun prescribed most often to Medicare patients was Gabapentin, with 1,205 prescriptions and refills. In total Dmitriy Grinshpun wrote 18,751 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 1,205 | 1,301 | 206 | $9,512 |
| Baclofen Generic | 1,175 | 1,316 | 216 | $6,483 |
| Duloxetine Hcl Generic | 1,088 | 1,204 | 174 | $14K |
| Mirtazapine Generic | 1,075 | 1,171 | 174 | $11K |
| Donepezil Hcl Generic | 755 | 856 | 118 | $3,346 |
| Diclofenac Sodium Generic | 720 | 757 | 113 | $195K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 662 | 790 | 97 | $5,478 |
| Escitalopram Oxalate Generic | 626 | 709 | 126 | $2,575 |
| Naproxen Generic | 606 | 623 | 110 | $3,966 |
| Meloxicam Generic | 580 | 624 | 135 | $1,157 |
| Divalproex Sodium Generic | 503 | 573 | 104 | $6,510 |
| Amitriptyline Hcl Generic | 499 | 559 | 99 | $3,250 |
| Primidone Generic | 383 | 425 | 61 | $4,958 |
| Lamotrigine Generic | 371 | 392 | 56 | $1,889 |
| Levetiracetam Generic | 362 | 421 | 56 | $7,298 |
Brand drugs: - claims; generic drugs: 16,324 claims; opioid claims: 255.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dmitriy Grinshpun $12K ($12K in general payments such as food, travel and fees) from 24 companies. The largest payer was Abbvie Inc. with $8,119.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 48 | $8,119 |
| SK Life Science, Inc. | 17 | $555 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 11 | $500 |
| Axsome Therapeutics, Inc. AXSM | 16 | $461 |
| Lundbeck LLC | 14 | $382 |
| Neurocrine BioSciences, Inc. NBIX | 12 | $280 |
| UCB, Inc. UCB.BR | 11 | $179 |
| Pfizer Inc. PFE | 8 | $167 |
| MDD US Operations, LLC | 7 | $153 |
| Vanda Pharmaceuticals Inc. VNDA | 7 | $150 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.